219 related articles for article (PubMed ID: 31840103)
1. Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repair.
Sansbury BM; Hewes AM; Kmiec EB
Commun Biol; 2019; 2():458. PubMed ID: 31840103
[TBL] [Abstract][Full Text] [Related]
2. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
Zhang WW; Matlashewski G
mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
[TBL] [Abstract][Full Text] [Related]
3. Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells.
Wang Y; Liu KI; Sutrisnoh NB; Srinivasan H; Zhang J; Li J; Zhang F; Lalith CRJ; Xing H; Shanmugam R; Foo JN; Yeo HT; Ooi KH; Bleckwehl T; Par YYR; Lee SM; Ismail NNB; Sanwari NAB; Lee STV; Lew J; Tan MH
Genome Biol; 2018 May; 19(1):62. PubMed ID: 29843790
[TBL] [Abstract][Full Text] [Related]
4. The Diversity of Genetic Outcomes from CRISPR/Cas Gene Editing is Regulated by the Length of the Symmetrical Donor DNA Template.
Hewes AM; Sansbury BM; Kmiec EB
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33008045
[TBL] [Abstract][Full Text] [Related]
5. gRNA Sequence Heterology Tolerance Catalyzed by CRISPR/Cas in an In Vitro Homology-Directed Repair Reaction.
Hewes AM; Sansbury BM; Barth S; Tarcic G; Kmiec EB
Mol Ther Nucleic Acids; 2020 Jun; 20():568-579. PubMed ID: 32330873
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editing.
Paulsen BS; Mandal PK; Frock RL; Boyraz B; Yadav R; Upadhyayula S; Gutierrez-Martinez P; Ebina W; Fasth A; Kirchhausen T; Talkowski ME; Agarwal S; Alt FW; Rossi DJ
Nat Biomed Eng; 2017 Nov; 1(11):878-888. PubMed ID: 31015609
[TBL] [Abstract][Full Text] [Related]
7. Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair.
Schubert MS; Thommandru B; Woodley J; Turk R; Yan S; Kurgan G; McNeill MS; Rettig GR
Sci Rep; 2021 Sep; 11(1):19482. PubMed ID: 34593942
[TBL] [Abstract][Full Text] [Related]
8. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
10. Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.
Li G; Zhang X; Wang H; Liu D; Li Z; Wu Z; Yang H
Int J Biochem Cell Biol; 2020 Aug; 125():105790. PubMed ID: 32534122
[TBL] [Abstract][Full Text] [Related]
11. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52.
Shao S; Ren C; Liu Z; Bai Y; Chen Z; Wei Z; Wang X; Zhang Z; Xu K
Int J Biochem Cell Biol; 2017 Nov; 92():43-52. PubMed ID: 28928041
[TBL] [Abstract][Full Text] [Related]
12. Chlamydomonas POLQ is necessary for CRISPR/Cas9-mediated gene targeting.
Sizova I; Kelterborn S; Verbenko V; Kateriya S; Hegemann P
G3 (Bethesda); 2021 Jul; 11(7):. PubMed ID: 33836052
[TBL] [Abstract][Full Text] [Related]
13. Opportunities and challenges with CRISPR-Cas mediated homologous recombination based precise editing in plants and animals.
Singh S; Chaudhary R; Deshmukh R; Tiwari S
Plant Mol Biol; 2023 Jan; 111(1-2):1-20. PubMed ID: 36315306
[TBL] [Abstract][Full Text] [Related]
14. Proximal binding of dCas9 at a DNA double strand break stimulates homology-directed repair as a local inhibitor of classical non-homologous end joining.
Feng YL; Liu SC; Chen RD; Sun XN; Xiao JJ; Xiang JF; Xie AY
Nucleic Acids Res; 2023 Apr; 51(6):2740-2758. PubMed ID: 36864759
[TBL] [Abstract][Full Text] [Related]
15. Gene Disruption Using CRISPR-Cas9 Technology.
Hu N; Malek SN
Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
[TBL] [Abstract][Full Text] [Related]
16. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
[TBL] [Abstract][Full Text] [Related]
17. A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells.
Carusillo A; Haider S; Schäfer R; Rhiel M; Türk D; Chmielewski KO; Klermund J; Mosti L; Andrieux G; Schäfer R; Cornu TI; Cathomen T; Mussolino C
Nucleic Acids Res; 2023 May; 51(9):4660-4673. PubMed ID: 37070192
[TBL] [Abstract][Full Text] [Related]
18. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
19. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
Albadri S; Del Bene F; Revenu C
Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
[TBL] [Abstract][Full Text] [Related]
20. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
